Glaukos GKOS
NYSE GKOS
$187.60 -1.95 (-1.03%)
At close: Aug 20, 2026 · 1:19 PM UTC

Glaukos (GKOS) Return on Capital Employed Growth (3y) (2018 - 2026)

Glaukos (GKOS) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn -236.00
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 281.00
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 145.00
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 446.00
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -433.00
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 1,627.00
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn -62.00
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn -
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 370.00
10 Glaukos 11.03 Bn 10.92 Bn 151.59 Mn -1,100.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,100.00
Mar 31, 2026 -1,120.00
Dec 31, 2025 -1,480.00
Sep 30, 2025 -283.00
Jun 30, 2025 -730.00
Mar 31, 2025 -1,040.00
Dec 31, 2024 -1,067.00
Sep 30, 2024 -1,288.00
Jun 30, 2024 -856.00
Mar 31, 2024 -339.00
Dec 31, 2023 -178.00
Mar 31, 2023 -2.00
Dec 31, 2022 113.00
Sep 30, 2022 -4.00
Jun 30, 2022 217.00
Mar 31, 2022 477.00
Dec 31, 2021 441.00
Sep 30, 2021 654.00
Jun 30, 2021 -273.00
Mar 31, 2021 -788.00